PMC:7781431 / 749-1083 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":177,"end":204},"obj":"Species"},{"id":"34","span":{"begin":206,"end":234},"obj":"Species"},{"id":"35","span":{"begin":240,"end":257},"obj":"Species"},{"id":"41","span":{"begin":81,"end":98},"obj":"Chemical"},{"id":"46","span":{"begin":64,"end":76},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Tax:12814"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:12721"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:11103"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolving lipids mediators have shown great promise for the treatment of Herpes simplex virus, respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus. Based on this, studies are being conducted on their therapeutic effects in "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":212,"end":228},"obj":"Phenotype"},{"id":"T4","span":{"begin":240,"end":249},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002721"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"s as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolving lipids mediators have shown great promise for the treatment of Herpes simplex virus, respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus. Based on this, studies are being conducted on their therapeutic effects in "}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":78,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"s as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolving lipids mediators have shown great promise for the treatment of Herpes simplex virus, respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus. Based on this, studies are being conducted on their therapeutic effects in "}